Technical Analysis for NVS - Novartis AG

Grade Last Price % Change Price Change
F 96.73 0.89% 0.85
NVS closed up 0.89 percent on Thursday, March 28, 2024, on approximately normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Down Up

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Stochastic Buy Signal Bullish 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup 0.89%
Oversold Stochastic Weakness 0.89%
Narrow Range Bar Range Contraction 1.53%
Oversold Stochastic Weakness 1.53%
Oversold Stochastic Weakness 1.04%
NR7 Range Contraction 0.52%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 8 hours ago
Rose Above 200 DMA about 8 hours ago
Up 1% about 8 hours ago
Up 1 ATR about 8 hours ago
60 Minute Opening Range Breakout about 9 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Novartis AG Description

Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism, respiratory, and other medicines. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines, and blood testing and molecular diagnostics products to prevent the spread of infectious diseases. Its Consumer Health division consists of two divisions, including over-the-counter medicines that offer readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Biotechnology Pharmaceutical Drugs Pharmacy Infectious Diseases Eye Medication Neuroscience Ophthalmology Antibiotics Animal Health Eyewear Ophthalmic Diagnostic Products Healthcare Products Molecular Diagnostics Blood Test Disposable Products Metabolism Disposable Product Prescription Drugs Active Pharmaceutical Ingredients Primary Care Lenses Contact Lens Contact Lenses Surgical Equipment Eye Care Intraocular Lens Over The Counter Drug Eye Care Products Lens Care Products

Is NVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 104.772
52 Week Low 88.2772
Average Volume 1,441,868
200-Day Moving Average 96.76
50-Day Moving Average 99.10
20-Day Moving Average 97.71
10-Day Moving Average 96.15
Average True Range 1.05
RSI (14) 45.36
ADX 18.48
+DI 29.57
-DI 33.33
Chandelier Exit (Long, 3 ATRs) 98.67
Chandelier Exit (Short, 3 ATRs) 98.21
Upper Bollinger Bands 101.25
Lower Bollinger Band 94.16
Percent B (%b) 0.36
BandWidth 7.26
MACD Line -0.85
MACD Signal Line -0.70
MACD Histogram -0.1452
Fundamentals Value
Market Cap 197.72 Billion
Num Shares 2.04 Billion
EPS 4.10
Price-to-Earnings (P/E) Ratio 23.59
Price-to-Sales 4.40
Price-to-Book 4.43
PEG Ratio 0.78
Dividend 3.92
Dividend Yield 4.05%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 98.31
Resistance 3 (R3) 98.29 97.74 98.04
Resistance 2 (R2) 97.74 97.34 97.75 97.95
Resistance 1 (R1) 97.24 97.09 97.49 97.26 97.87
Pivot Point 96.69 96.69 96.82 96.70 96.69
Support 1 (S1) 96.19 96.29 96.44 96.21 95.59
Support 2 (S2) 95.64 96.04 95.65 95.51
Support 3 (S3) 95.14 95.64 95.42
Support 4 (S4) 95.16